Showing results (361-370 of 627) with videos related to

Sort By:
Pageof 63
Biomaterials|June 25, 2010
Preservation of dendritic cell function upon labeling with amino functionalized polymeric nanoparticlesO Zupke, E Distler, D Baumann, et al.
The American Journal of Emergency Medicine|July 1, 1990
Success rates for initiation of intravenous therapy en route by prehospital care providersC M Slovis, E W Herr, D Londorf, et al.
Cancer|October 1, 1996
The National Cancer Data Base report on bladder carcinoma. The American College of Surgeons Commission on Cancer and the American Cancer SocietyN E Fleshner, H W Herr, A K Stewart, et al.
Bladder Cancer (Amsterdam, Netherlands)|March 12, 2019
The Outcome of Post-Chemotherapy Retroperitoneal Lymph Node Dissection in Patients with Metastatic Bladder Cancer in the RetroperitoneumNick W Liu, Katie S Murray, S Machele Donat, et al.
Neurotoxicology and Teratology|March 12, 2022
Impacts of a perinatal exposure to manganese coupled with maternal stress in rats: Tests of untrained behaviorsKatherine L McDaniel, Tracey E Beasley, Wendy M Oshiro, et al.
Genomics|January 20, 1995
The gene encoding the VP16-accessory protein HCF (HCFC1) resides in human Xq28 and is highly expressed in fetal tissues and the adult kidneyA C Wilson, J E Parrish, H F Massa, et al.
The Journal of Urology|May 14, 2013
Intravesical gemcitabine for high risk, nonmuscle invasive bladder cancer after bacillus Calmette-Guérin treatment failureItay A Sternberg, Guido Dalbagni, Ling Y Chen, et al.
BJU International|September 24, 2013
Preoperative serum albumin is associated with mortality and complications after radical cystectomyTullika Garg, Ling Y Chen, Philip H Kim, et al.
The Journal of Urology|June 1, 1989
Flow cytometry as a predictor of response and progression in patients with superficial bladder cancer treated with bacillus Calmette-GuerinP R Bretton, H W Herr, M Kimmel, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 16, 1999
Identification of naturally processed and HLA-presented Epstein-Barr virus peptides recognized by CD4(+) or CD8(+) T lymphocytes from human bloodW Herr, E Ranieri, A Gambotto, et al.
Pageof 63